HTA: why it matters in the changing balance of purchasing power
This article was originally published in Clinica
Executive Summary
As purchasing decision-making shifts increasingly from clinicians to purchasing administrators equipped with a growing array of tools to measure the effectiveness of medical devices, how should manufacturers respond? Consultant Mark Charny* examines the implications of the changing dynamics and suggests how companies can best position themselves to manage the tricky business of being able to make clinical and non-clinical decision-makers receptive to their products